This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Wide Field Looking to Trim Weight

American bellies coast to coast are still bulging from turkey and stuffing post-Thanksgiving. In other words, it's a lot like any other day of the year -- just add sweet-potato casserole and pumpkin pie.

Eating, after all, is fun. Diets, not so much, and exercise -- let's face it -- is flat-out work. The problem with this is that a few hundred unneeded calories a day, gigantic portion sizes and years of being chained to a desk have a way of making people think the bathroom scale must be broken and that their walls are hung with fun-house mirrors.

Of course, being overweight isn't simply a result of poor dietary habits and physical inactivity for everyone, because genetics can play a role, too. The good news is there are options, both for those looking to shed excess weight and for investors hoping to add some heft to their accounts.

Already several medical treatments for fighting obesity are on the market or in trials, and for some people, surgery is being welcomed as a quick way to slim down after diet and exercise have failed.

As obesity rates rise, and with Americans spending $33 billion a year on weight-loss measures, according to the National Institutes of Health, it's no wonder the number of firms grabbing for a share of the market seems to be growing.

Benefit From Broadening

Among the multiple devices that are available, sales of the BioEnterics Lap-Band, a gastric band designed to restrict stomach size, quadrupled between 2001 and 2004, according to Inamed (IMDC), its maker. Shares of the Santa Barbara, Calif., company were recently at $83.15, compared with a price of around $15 before the 2001 launch of the device.

Granted, Inamed has additional factors contributing to the stock price -- namely hopes it will get a silicone-gel breast implant approved for cosmetic use in the U.S. and the fact that it's being chased by two suitors -- but it still started 2005 around $63.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
IMDC $0.03 0.00%
MDT $77.61 0.00%
MYGN $33.59 0.00%
STJ $73.47 0.00%
AAPL $130.28 0.00%

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs